Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing
On October 2, 2008, EntreMed, Inc. (the "Company") announced that effective October 3, 2008, the listing of the Company's common stock will be transferred from the Nasdaq Global Market to the Nasdaq Capital Market.
As previously announced on April 7, 2008, the Company received a letter from the Nasdaq Stock Market advising that the Company did not meet the minimum $1.00 per share bid price requirement for continued inclusion on the Nasdaq Global Market pursuant to Nasdaq Marketplace Rule 4450(a)(5). On September 22, 2008, the Company submitted a transfer application to the Nasdaq Stock Market to transfer the listing of its common stock to the Nasdaq Capital Market. Upon transfer to the Nasdaq Capital Market, the Company will be afforded an additional compliance period of 180 calendar days, or until March 30, 2009, to comply with the minimum $1.00 per share bid price requirement of the Nasdaq Capital Market.
The Company's common stock will continue to trade under the symbol "ENMD." The Nasdaq Stock Market operates both the Nasdaq Global Market and the Nasdaq Capital Market. All companies listed on the Nasdaq Capital Market must meet certain financial requirements and adhere to similar corporate governance standards as companies listed on the Nasdaq Global Market.
On October 2, 2008, the Company issued the press release attached to this Current Report as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits
(d) Exhibits. The following document is filed as an exhibit to this report.

99.1 Press Release of EntreMed, Inc., dated October 2, 2008.

---